Government's Endorsement of Caldicott2 is a Landmark Milestone for Patient Privacy

FairWarningFairWarning Inc., the inventor and global leader in patient privacy monitoring, has welcomed the UK government's response to the Caldicott Review, describing its decision to accept all of the recommendations in the review as "a significant step towards transparent care and a landmark milestone for both patients and the NHS."

But the company says the announcement, which coincides with the publication of the Health & Social Care Information Centre's (HSCIC) guide to confidentiality in health and social care, is just the latest step in the long journey towards electronic healthcare - and has urged healthcare stakeholders to work collaboratively to drive a culture of privacy throughout the NHS and ensure that the Caldicott2 recommendations are fully implemented within 12 months.

The Caldicott report was first published in April 2013, following an independent review into how information about individuals is shared across the health and social care system. FairWarningwas highly supportive of the original recommendations and is therefore extremely encouraged by the government’s decision to endorse all of the review's proposals.

FairWarning shares the government's view that effective information sharing will not only lead to better health outcomes, but it will also improve care pathways and enhance the patient experience. The company wholly supports the finding that there is no contradiction between increasing data sharing for care and improving the safeguards for personal confidential data.

However, electronic healthcare can only succeed if patients feel in greater control of their personal confidential information and are confident that the NHS is ensuring that information is secure, protected and shared appropriately. As such, moves to harness the power of information must be underpinned by robust information governance and information risk management processes that protect patient confidentiality.

Tim Dunn, General Manager for FairWarning UK commented: "Tools to help NHS professionals provide transparency on who is accessing patient records, and enabling trusts to monitor access proactively, are readily available and being successfully deployed in parts of the UK. We welcome that, in its response to Calidicott2, the government has acknowledged the implementation of privacy breach monitoring in Scotland. We believe that the full implementation of these recommendations could bring the rest of the UK to the high standard levels achieved in NHS Scotland, and ensure information assurance for UK trusts."

FairWarning considers the government's guidelines an important framework to ensure transparency and accountability for patient privacy. However, the company also believes the NHS' ability to implement the recommendations will be pivotal to the expansion of trust in digital healthcare.

Tim Dunn concluded: "It is now critical that Dame Fiona’s recommendations are implemented in a timely fashion, in line with the deadlines set out in the Caldicott Review and the response of the Department of Health (DH). Jeremy Hunt’s ambitions for electronic healthcare rely on executing this plan and protecting patient privacy will be at the heart of those efforts.

"The development of electronic healthcare models will indeed require both a step change and a concerted effort at national and local level. The time to act is now and FairWarning looks forward to supporting the DH and its partners in achieving these important goals."

About Caldicott2
The independent Information Governance Review led by Dame Fiona Caldicott, entitled 'Information: to share or not to share?' and also known as Caldicott2, was set up in February 2012 and delivered its final report and recommendations in April 2013. The aim of the review was to advise on how to achieve a better balance between protecting and sharing confidential personal information. The review produced a set of 7 revised "Caldicott Principles" and 26 specific recommendations. Dame Fiona will now chair an independent panel to oversee and scrutinise implementation of the review's recommendations and to provide advice on information governance issues.

About FairWarning, Inc.
FairWarning empowering care providers to grow their reputation for protecting confidentiality, scale their digital health initiatives and comply with complex privacy laws. By partnering with FairWarning, care providers are able to direct their focus on delivering the best patient outcomes possible while receiving expert, sustainable and affordable privacy and compliance solutions. Customers consider FairWarning such as ARRA HITECH privacy and meaningful use criteria, HIPAA, UK and EU Data Protection, and Canadian provincial healthcare privacy law.

Most Popular Now

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...